This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolter, N.
Right arrow Articles by Klugman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolter, N.
Right arrow Articles by Klugman, K. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2009, p. 1319-1324, Vol. 47, No. 5
0095-1137/09/$08.00+0     doi:10.1128/JCM.02280-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Molecular Characterization of Emerging Non-Levofloxacin-Susceptible Pneumococci Isolated from Children in South Africa{triangledown}

Nicole Wolter,1* Mignon du Plessis,1 Anne von Gottberg,1 Linda de Gouveia,1 and Keith P. Klugman1,2

Respiratory and Meningeal Pathogens Research Unit, National Institute for Communicable Diseases, Medical Research Council, and University of the Witwatersrand, Johannesburg, South Africa,1 Hubert Department of Global Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia2

Received 28 November 2008/ Returned for modification 16 January 2009/ Accepted 19 February 2009

Fluoroquinolones are not indicated for use for the treatment of pneumonia in children; however, non-levofloxacin-susceptible Streptococcus pneumoniae (NLSSP) has emerged in South Africa among children receiving treatment for multidrug-resistant tuberculosis. This study aimed to genotypically characterize NLSSP isolates. Invasive isolates were collected through active national laboratory-based surveillance for invasive pneumococcal disease (IPD) from 2000 through 2006 (n = 19,404). Carriage studies were conducted at two hospitals for patients with tuberculosis in two provinces. Phenotypic characterization was performed by determination of MICs and serotyping. Fluoroquinolone resistance mutations were identified, and clonality was investigated by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Twelve non-levofloxacin-susceptible cases of IPD were identified, and all were in children <15 years of age. Ten isolates were serotype 19F and formed two clusters according to their PFGE profiles, antibiogram types, and fluoroquinolone resistance-conferring mutations. All nine carriage isolates from children in hospital A were NLSSP, serotype 19F, were indistinguishable by PFGE, and were related to invasive isolates in cluster 2. Of 26 child carriers in hospital B, 22 (85%) were colonized with NLSSP. The isolates were indistinguishable by PFGE, although they displayed two serotypes, serotypes 19F and 23F. The isolates were related to invasive isolates in cluster 1; however, higher levofloxacin MICs and different fluoroquinolone resistance mutations were suggestive of horizontal gene transfer. A serotype 23F carriage isolate displayed increased fitness compared with the fitness of an otherwise indistinguishable serotype 19F carriage isolate. These data suggest that a low-level non-levofloxacin-susceptible strain transformed into a highly resistant strain under antibiotic pressure and underwent capsular switching in order to have increased fitness.


* Corresponding author. Mailing address: Respiratory and Meningeal Pathogens Research Unit, National Institute for Communicable Diseases, Private Bag X4, Sandringham 2131, Gauteng, South Africa. Phone: 27 11 555 0352. Fax: 27 11 555 0437. E-mail: nicolew{at}nicd.ac.za

{triangledown} Published ahead of print on 4 March 2009.


Journal of Clinical Microbiology, May 2009, p. 1319-1324, Vol. 47, No. 5
0095-1137/09/$08.00+0     doi:10.1128/JCM.02280-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.